Enter your information to understand your Anti-TG levels.

The History of Anti-TG

Thyroglobulin antibodies hold the distinction of being the very first thyroid autoantibody ever identified, discovered in 1956 by British researchers Deborah Doniach and Ivan Roitt at Middlesex Hospital in London while studying patients with the chronic thyroid inflammation first described decades earlier, in 1912, by Japanese surgeon Hakaru Hashimoto. Around this same period, American researchers Ernst Witebsky and Noel Rose ran a parallel and equally important experiment, injecting laboratory rabbits with purified thyroglobulin and successfully triggering an autoimmune thyroiditis nearly identical to the human disease, offering the first direct experimental proof that a single isolated protein could provoke the immune system into attacking an entire organ. Together, these two lines of research, one purely observational in humans and one deliberately experimental in animals, arrived at the very same conclusion almost simultaneously, within just a few years of each other.

What Anti-TG Actually Is

Thyroglobulin is a large protein manufactured exclusively inside the thyroid gland, where it serves as the physical scaffold on which thyroid hormone is actually built and stored before being released gradually into the bloodstream as the body needs it. Anti-TG antibodies appear when the immune system mistakenly targets this storage protein, a hallmark sign of autoimmune thyroid conditions, most commonly Hashimoto's thyroiditis, and occasionally present alongside Graves' disease as well, though less consistently. Beyond diagnosing autoimmune disease, this antibody also has a distinct second clinical use: in patients previously treated for thyroid cancer, thyroglobulin itself is used as a tumor marker to monitor for cancer recurrence, and anti-TG antibodies are checked alongside it because their presence can distort that monitoring test's accuracy, sometimes masking a truly rising thyroglobulin level that would otherwise signal a real problem.

How Anti-TG Is Measured

The earliest assays used a technique called tanned red cell hemagglutination, developed specifically by Roitt and Doniach in the 1950s, where antibody-coated red blood cells would visibly clump together in a positive sample under simple microscopic inspection, without any need for complex instrumentation. This gave way over subsequent decades to radioimmunoassay and eventually to the automated chemiluminescent immunoassays used almost universally today, which measure a light signal generated in direct proportion to how much antibody binds a purified thyroglobulin antigen on an automated laboratory platform. These modern methods are considerably more sensitive and can reliably detect much smaller antibody quantities than the original mid-century techniques ever could achieve, even in trace amounts.

Scientists Behind the Science

Deborah Doniach and Ivan Roitt's 1956 discovery stands as the founding moment of thyroid autoimmunity research, proving for the first time that a specific antibody circulating in human blood corresponded directly to a specific, previously mysterious disease process. Ernst Witebsky and Noel Rose's rabbit experiments provided the essential experimental counterpart to that human finding, and their combined body of work is frequently credited with establishing what later became known as Witebsky's postulates — a formal set of scientific criteria still used by researchers today to determine whether a given disease truly qualifies as autoimmune in origin, well beyond the thyroid gland alone, across the entire field of immunology and clinical medicine.